Skip to main navigation Skip to search Skip to main content

BAG-1M is up-regulated in hippocampus of Alzheimer's disease patients and associates with tau and APP proteins

  • Weizmann Institute of Science

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

The accumulation of tau and amyloid beta proteins is the major molecular pathology of Alzheimer's disease (AD). The mechanisms leading to the accumulation of these proteins are not completely clear. Hsc-70/Hsp-70, a chaperone protein, has been shown to bind both these proteins and regulate their degradation. We have previously shown that the co-chaperone protein BAG-1 can inhibit the degradation of tau by forming a complex with Hsc-70 and tau. In this current work, we show that there is an increase in the BAG-1M isoform in the hippocampus of AD patients. In addition, BAG-1 binds to both tau and amyloid precursor protein physically, and is found highly expressed in the same neurons that contain intracellular tau or amyloid in hippocampal sections from AD patients. Over-expression of BAG-1M in cell culture also induced an increase in both tau and amyloid precursor protein levels. In conclusion, we report a specific increase of BAG-1M in human AD patients, which is both physically and functionally associated to the two major molecular markers of AD.

Original languageEnglish
Pages (from-to)1168-1178
Number of pages11
JournalJournal of Neurochemistry
Volume109
Issue number4
DOIs
StatePublished - May 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • APP
  • Alzheimer's disease
  • BAG-1
  • Chaperones
  • Tau

Fingerprint

Dive into the research topics of 'BAG-1M is up-regulated in hippocampus of Alzheimer's disease patients and associates with tau and APP proteins'. Together they form a unique fingerprint.

Cite this